Phytochemicals and Nano-Phytopharmaceuticals: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Vivi Li and Version 1 by Alok Paul.

Nanomedicines emerged from nanotechnology and have been introduced to bring advancements in treating multiple diseases. Nano-phytomedicines are synthesized from active phytoconstituents or plant extracts. Advancements in nanotechnology also help in the diagnosis, monitoring, control, and prevention of various diseases. The field of nanomedicine and the improvements of nanoparticles has been of keen interest in multiple industries, including pharmaceutics, diagnostics, electronics, communications, and cosmetics. In herbal medicines, these nanoparticles have several attractive properties that have brought them to the forefront in searching for novel drug delivery systems by enhancing efficacy, bioavailability, and target specificity. 

  • nanomaterials
  • locomotor disorder
  • dermal disorder
  • urogenital disorder
  • phytopharmaceuticals

1. Introduction

Physicians and patients have recognized the use of herbal medicine since ancient times [1]. For instance, the first-ever plant-derived painkiller, morphine which belongs to the benzylisoquinoline class of alkaloid, was isolated from Papaver somniferum L. (Papaveraceae) and authorized to be used in 1827 [2]. Herbal medicines are well known for their better therapeutic performance as well as lesser side effects compared to modern medicines. The demand for phytochemicals and plant products has been increasing rapidly in many areas of medicine, as in the treatment of dermal, urogenital, and locomotor disorders. Advanced phytopharmaceutical research especially with novel drug delivery systems by applying nanotechnology plays an important role in troubleshooting scientific needs with the determination of the pharmacokinetics, mechanism of action, site of action, accurate dosage, improved bioavailability, and reduced toxicity of various herbal medicines [3,4][3][4]. Several safety concerns related to biocompatibility, possible toxicity (of unknown natural compounds), and lack of enough clinical trials on medicinal plants and herbal medicines can be resolved by the implementation of nano-based drug delivery systems [5,6,7][5][6][7]. Thus, herbal medicines can be used for the treatment of a wide range of ailments, including dermal, urogenital, and locomotor disorders.
Nanoparticles are often classified as particles of less than 100 nm in diameter. They occur extensively in nature as products of photochemical, plant, and algae activity and have also been created as by-products of combustion and food cooking for thousands of years [8]. There are various kinds of nanosystems available, such as niosomes, liposomes, nanostructured lipid carriers (NLCs), and nanoemulsions. Niosomes are defined as microscopic vesicles composed of non-ionic surfactants, liposomes as microscopic spherical vesicles having one or more phospholipid bilayer membrane, NLCs as novel nano-sized pharmaceutical formulations composed of solid and liquid lipids, surfactants, and co-surfactants. Nanoemulsions as nano-sized emulsions have droplet sizes between 20 and 500 nm, respectively. Nanomedicine is the application of nanoscale materials such as nanoparticles for the diagnosis, monitoring, control, prevention, and treatment of disease [9]. The field of nanomedicine and the application of nanoparticles has been of keen interest in several industries, such as electronics, communications, cosmetics, biology, and medicine [10]. In medicine, these nanoparticles have various attractive properties that have brought them to the forefront in the search for novel drug delivery systems with most advances in the utilization of nanoparticle drug delivery for the treatment of cancer with several nanotherapies being used clinically after approval by the FDA in the United States of America [11,12][11][12]. The properties exhibited by nanoparticles include a high surface-to-volume ratio, high surface energy, unique mechanical, thermal, electrical, magnetic, and optical behaviors [13].
The term “nanotechnology” is derived from a Greek word that means dwarf, which employs the concepts of engineering and manufacturing at the molecular level [14]. The advantages generated by the use of nanotechnology can assure the revolutionary changes in herbal medicines along with several other multidisciplinary emerging applications in chemistry and physics. The reason behind the achievements of nanotechnology in medicine includes the possibility of working at the same scale of many biological processes, cellular mechanisms, and organic molecules. For this reason, medicine has looked at nanotechnology for the ideal solution in the treatments of several diseases. Furthermore, the methodology has drawn attention toward providing treatments in a safe and effective form [15].
From the existing literature, the increasing trend in nanoformulation using phytochemicals studies has been remarkable, particularly from the last 5 years (from 2018 to date) and it is commonly investigated against cancer-related disorders. Thus, it is timely for us to write a focused review on the current situation of the application of nanoformulations with phytochemicals and herbal medicines. This review s entry therefore focuses on the potential of herbal medicines highlighting the successful application of nanotechnology to treat some diseases, specifically dermal, urogenital, and locomotor activities. In addition, this reviewentry aims to understand the justification and significance of using nanotechnology-derived phytochemicals or herbal formulations (i.e., nano-phytopharmaceuticals) in the three specific disorders based on locomotion, skin, and urogenital conditions (Figure 1).
Figure 1. Representation of delivery of phytopharmaceutical using nanotechnology. The figure was made with www.biorender.com (access date: 15 March 2022).

2. Therapeutic Applications of Nano-Phytopharmaceuticals

2.1. Nano-Phytopharmaceuticals in Dermal Disorders

Dermatological disorders are prevalent worldwide and regarded as one of the major global burdens among various diseases [16]. Severe skin damage from burns or wounds as well as acne (i.e., often causes erythematous papulopustular lesions such as rash consisting of papules and pustules) can also lead to trauma and further psychosocial stresses besides possible pain or other aggravations caused by the disorder itself [17,18][17][18]. Dermatological disorders can be atopic dermatitis, alopecia (androgenic alopecia and alopecia areata, both indicating hair loss), hirsutism (growth of excess coarse body hair usually in women in places where hair is not supposed to grow), hyperhidrosis (excessive sweating), hidradenitis suppurativa (chronic and progressive inflammatory skin condition affecting groin, buttocks, and perineal and perianal regions), vitiligo, psoriasis, and melanoma [19].
Most dermatological disorders affect the outermost layer of the skin (horny layer), which is typically water repellent and dense, the latter characteristic acting as an effective barrier against rapid passage of any outward items, which may be chemicals or infectious agents. Topical therapeutic agents usually contain in combination the agent and a base-formulation, which facilitates the absorption of the agent. Drugs for dermatological disorders must cross the horny layer to get to the root of skin infection to produce their therapeutic effects. A low molecular weight of the therapeutic agent (20-300 kDa) enhances penetration of the horny layer or stratum corneum [20], which is further enhanced if the agent is applied as an oleaginous ointment, emulsified ointment, cream, or gel. Nanotechnology can be an important tool for the delivery of therapeutic agents for both topical and transdermal applications through engineered nanoparticles of drugs and enabling them to better reach their target sites. Various types of nanoformulations are available such as solid nanoparticles, liposomes, secosomes, transferosomes, ethosomes, niosomes, nanoemulsions (NE), nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNPs), and flexible nanovesicles [21].
Solid nanoparticles, such as zinc oxide and titanium dioxide nanoparticles (NPs) are mainly used in sunscreens to filter out UVA and UVB radiations. Studies on keratinocytes suggest that titanium dioxide nanoparticles are safer than zinc oxide, as zinc oxide NPs can generate reactive oxygen species within cells. Both NPs have been found to produce adverse effects in human keratinocytes in vitro following long-term exposure [22]. Liposomes are usually composed of cholesterol and phospholipids that show higher biocompatibility, improved solubility, and efficacy of lipophilic and amphiphilic drugs and thus facilitate the application of topical drugs [23].
Nanomaterials such as NLCs are prepared from a combination of solid lipid (SL) and liquid lipid (LL) ingredients. The use of LL in the manufacture of NLCs permits a greater drug load. The SLs include compounds such as glyceryl monostearate and glyceryl tripalmitate; the LLs include a more diverse variety of compounds such as oleic acid and squalene. Surfactants used in the preparation of NLCs include lecithin and Tween 80 [24]. Flexible or deformable nanovesicles have greater penetrability through biological barriers but thus far have seen limited use because of their physical and chemical instabilities. However, a recent study reported that flexible nanovesicles at a low density and containing 8% lactose and trehalose at a ratio of 1:4 have a spherical shape, smooth surface morphology in the lyophilized state, a whorl-like structure, high entrapment efficiency, and deformability after reconstitution; thus confirming their stability. Importantly, the secondary structure of insulin was well protected in the insulin-phospholipid complex deformable nanovesicles [25], which further confirmed their functional ability.
From the above section(s), it is apparent that nanovesicles and nanoparticles can play an important role in the delivery of drugs to target organs especially on skin. It is important because many drugs have poor aqueous solubility; thus limiting their bio-absorption. These lipophilic drugs can be encapsulated within nanovesicles as nanoparticles and then administered through suitable routes. Various nanotechnological approaches have been and still are experimented with towards a more efficacious treatment of skin disorders. The therapeutic nanoparticles comprise conventional drugs, crude extract of plants, and phytochemicals. For example, the ethanolic extract of Ocimum sanctum L. (Lamiaceae) reportedly has anti-aging properties on skin, as demonstrated by its anti-oxidant and anti-inflammatory properties, as well as its inhibitory features against hyaluronic acid and collagen fiber degradation inhibition [26]. The encapsulation of the ethanolic extract was completed in several types of nanodelivery systems, including NLCs, NEs, liposomes, and niosomes. Among the various delivery systems containing Ocimum sanctum L. (Lamiaceae) extract nanoparticles, NLC and NE were the most stable, with NLC delivering the highest amount of extract to the skin layer [27]. The ethosome gel was reported to deliver quercetin to treat inflammation, and amphotericin B to treat fungal infections [28,29][28][29]. Quercetin-loaded phospholipid vesicles containing, in addition, 5% polyethylene glycol demonstrated effectiveness in amelioration of skin inflammation induced by TPA (12-O-tetradecanoylphorbol-13-acetate). The nanoethosomal formulation exhibited a 3.5-fold higher skin deposition of amphotericin B, leading to a significant increase in anti-fungal activity against Candida albicans.
Application of various forms of nanodelivery systems for the treatment of skin disorders have been reviewed by Roberts et al. [21]. These include liposome, ethosome, and deformable liposome-based delivery of ketoconazole to treat dermatological fungal infections from Candida albican; the use of nanostructured lipid carrier-based gel to deliver clobetasol propionate to treat eczema; the use of solid lipid nanoparticles for delivery of artemisone and doxorubicin for the treatment of melanoma and squamous cell carcinoma, respectively. Silver nanoparticles have been used to treat scalp-based fungal infections caused by Malassezia furfur; and gold nanoparticles are used for the treatment of psoriasis. The use of tyrospheres (tyrosine-derived nanospheres) as a delivery medium for vitamin D3 has also proved to be effective for psoriasis treatment. It appears that there is enhanced absorption of vitamin D3 through this nano-treatment method [30]. In fact, as reviewed by Petit et al., the use of biodegradable nanocarriers for delivery of vitamin D3 or other therapeutics for psoriasis treatment includes nanospheres, nanocapsules, liposomes, ethosomes, solid lipid nanoparticles, and nanostructured lipid carriers [31].
Curcumin, which is derived from rhizomes of Curcuma longa L. (Zingiberaceae), containing nanomaterials, including lipid-based nanoparticles such as liposomes, niosomes, solid lipid nanoparticles, and nanostructured lipid carriers are used in various dermatological disorders such as psoriasis, dermatitis, bacterial, viral and fungal infections, burns, acne, vitiligo, arthritis, and skin cancer [32,33,34][32][33][34]. Lipid-based nanoparticles (NLCs and SLNPs) of curcumin have higher biocompatibility with skin layers, can increase their penetration into this organ and thus increase their solubility, stability, and therapeutic efficiencies [33] (Table 1). NLCs and SLNPs can also increase patient compliance by maintaining delayed and regulated release and improving their pharmacological activities [35,36][35][36].
Table 1.
 Role of nano-phytopharmaceutical formulations against various locomotor, skin, and urogenital disorders.
Plant Source Formulation Study Type Action Reference
Citrus fruits, onions, apples, parsley, sage, tea, and berries. Nanoencapsulated quercetin in zein nanoparticles (NPQ) Preclinical (rats) NPQ improved memory and cognitive ability in rats (but no effects on

locomotor activity test)		 [37,38][37][38]
Citrus fruits, onions, apples, parsley, sage, tea, and berries. Quercetin

nanoparticles		 Preclinical (rats) Quercetin nanoparticles improved memory and pathological damage

induced by scopolamine		 [39,40][39][40]
Berries, currants, grapes, red to purplish blue colored leafy vegetables, grains, roots, and tubers. Anthocyanin-loaded poly (ethylene glycol)-gold nanoparticles (PEG-AuNPs) Preclinical (mice) PEG-AuNPs improved amyloid-beta (Aβ1-42)

induced neuronal damage and neuroinflammation		 [41,42][41][42]
Curcuma longa L. (Zingiberaceae) Nano-curcumin particles Preclinical (mice) Enhanced memory, motor function, contextual fear [43]
Anamirtacocculus (L.) Wight and Arn. (Menispermaceae) A.cocculus NPs in cocc 30c, in a homeopathic formulation Preclinical Improved attention and motor functions in

sleep-deprived rats		 [44]
Solanum tuberosum L. (Solanaceae) S.tuberosum Lectin NPs Preclinical Helped improved drug delivery enhanced memory and

motor function		 [45]
Azadirachta indica A.Juss. (Meliaceae) Neem oil incorporated in argan-liposomes and argan-hyalurosomes by sonicating with argan oil, soy lecithin, and water In vitro Protected skin cells by reducing oxidative stress [46].
Curcuma longa L. (Zingiberaceae) Curcumin formulated with lipid-based nanoparticles such as liposomes, niosomes, solid lipid nanoparticles, and nanostructured lipid carriers Review Improved its penetration into skin and thus increased the solubility, stability, and therapeutic efficiencies of curcumin against various dermatological disorders such as psoriasis, dermatitis, bacterial, viral and fungal infections, burns, acne, arthritis, and skin cancer [33,34][33][34]
Curcuma longa L. (Zingiberaceae) C. longa leaves extract

Silver nanoparticles (CL-AgNPs) loaded cotton fabric		 In vitro Enhanced wound healing and antimicrobial activity on skin [47]
Curcuma longa L.(Zingiberaceae) Solid lipid

nanoparticles

(SLN-curcuminoids)		 Ex vivo (Sheep ear skin) Showed good

spreadability and

stability on skin		 [48]
Curcuma longa L. (Zingiberaceae) Curcumin

nanoparticles

(curc-NPs)		 Preclinical (rats) Improved erectile

response in diabetic male rats		 [49,50][49][50]
Panax ginseng C.A.Mey (Araliaceae) P.ginseng

nanoparticles		 Preclinical (rats) Improved serum testosterone secretion and

decrease sperm

abnormalities in male rats		 [51]
Oxaliscorniculata L. (Oxalidaceae) Aqueous extract of

O. corniculata and its biofabricated silver nanoparticles (AgNPs)		 In vitro Effective against urinary tract infection (UTI)

causing microorganisms		 [52]
Anogeissusacuminata Wall.(Combretaceae) Aqueous leaf extract of A. acuminata and its AgNPs In vitro Effective against multidrug resistant UTI causing bacteria [53]
Passiflora caerulea L. (Passifloraceae) Zinc oxide nanoparticles (ZnO NPs) using P. caerulea extract In vitro Effective against multidrug resistant UTI causing bacteria [54]
Catharanthus roseus (L.) G. Don (Apocynaceae) Sulphur nanoparticles (SNPs) produced from

C. roseus leaf extract		 In vitro Effective against

multidrug resistant UTI causing bacteria		 [55]
Mimosa pudica L. (Fabaceae) Sulphur nanoparticles (SNPs) produced from

M. pudica alcoholic extracts		 In vitro Antibacterial effects on uropathogenic E. coli (UPEC) and S. aureus and other UTI pathogens [56]
Nigella sativa L. (Ranunculaceae) Sulphur nanoparticles (SNPs) produced from seeds of

N. sativa L.

alcoholic extracts		 In vitro Antibacterial effects on UPEC and S. aureus and other UTI pathogens [57]
Rauwolfia serpentina L. (Apocynaceae) Biologically synthe-sized gold nanopar-ticles with aqueous leaf extract of

R. serpentina L.		 In vitro Antibacterial effects on

E. coli and S. aureus		 [58]
A phospholipid-based nanoformulation containing neem oil, derived from Azadirachta indica A. Juss. (Meliaceae), was incorporated in argan-liposomes and argan-hyalurosomes by sonicating with argan oil and soy lecithin in the presence of water, as described by Manca and colleagues [46]. The formulation contained vesicles of 140 nm in diameter with negative charge [46], which protected skin cells from oxidative stress.

2.2. Nano-Phytopharmaceuticals in Urogenital Disorders

The application of nanotechnology to deliver herbal molecules permits bioactive compounds for targeted site delivery. This application is crucial for the management of menopause as the targeted delivery can minimize the side effects of the herbal product, which contains hormone-like activity. Hormone replacement therapy (HRT) is the primary management strategy for menopause. Although the benefits of using HRT (estrogen and progesterone) for the management of moderate-to-severe menopausal symptoms outweigh the risk, the non-selective delivery of the hormones may cause increased risks of cerebrovascular diseases, such as stroke [61][59]. Herbal medicines are promising alternatives for the management of menopause. Phytoestrogen is a plant-derived compound that is structurally and/or functionally similar to estrogen. Plant compounds such as soy, red clover, hop, and other botanicals contain naturally occurring phytoestrogens [62][60]. Genistein is a primary phytoestrogen compound of soybean which is poorly soluble in an aqueous medium. Its poor aqueous solubility and low serum concentration after administration warrant the development of a novel drug delivery system [63][61]. Encapsulation of genistein in Fe3O4-carboxymethylated chitosan nanoparticles and EudragitR E cationic copolymers improves water solubility, leading to better absorption from the gastrointestinal tract [63,64][61][62]. A low dose of phytoestrogen is associated with the development and progression of breast cancer in vitro and in vivo [65][63]. Activation of estrogen receptors in the breast by phytoestrogen promotes the growth of breast cancer. These limitations can be overcome with the incorporation of a nanotechnology-based drug delivery system. Encapsulating phytoestrogen in nanoparticles may help delivery of the bioactive compounds to the estrogen receptors in endothelium and vascular smooth muscle specifically. The agonist effect of estrogen receptors on vascular smooth muscle helps to relieve vasomotor symptoms (hot flash, night sweat) in menopausal women. The extended-release activity of the herbal preparation can be achieved through encapsulation into nanocarriers, such as multivesicular liposomes. This approach is valuable in delivering bioactive compounds which are intended to produce long-lasting action. Genistein nanoparticle preparation has been widely used for anticancer therapy [66][64]. However, its potential as a phytoestrogen to treat menopause is not yet fully elucidated.
Herbal products such as rhizome extract of wild yam (Dioscorea villosa L. (Dioscoreaceae), root extract of Dong Quai (Angelica sinensis (Oliv.) Diels (Apiaceae)), evening primrose oil (Oenothera biennis L. (Onagraceae)), dried root of Maca (Lepidium meyenii Walp. (Brassicaceae)) are commonly used among menopausal women to relieve menopausal symptoms [67][65]. Black cohosh (Cimicifuga racemosa L.) Nutt. (Ranunculaceae) is one of the common herbal products that has been used among indigenous people for the management of menopausal symptoms. Several mechanisms of action of black cohosh have been proposed: selective estrogen receptor modulation, serotoninergic pathway, anti-oxidation, and anti-inflammation [68][66]. The blood-brain barrier is a challenge for the delivery of bioactive compounds, which act centrally. Formulating black cohosh in nanoparticles may help enhance the crossing of the bioactive compound through the blood-brain barrier. This novel formulation increases the selectivity of black cohosh bioactive compounds towards the central serotoninergic pathway in the brain [69][67].

References

  1. Kesarwani, K.; Gupta, R.; Mukerjee, A. Bioavailability enhancers of herbal origin: An overview. Asian Pac. J. Trop. Biomed. 2013, 3, 253–266.
  2. Patridge, E.; Gareiss, P.; Kinch, M.S.; Hoyer, D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov. Today 2016, 21, 204–207.
  3. Bonifácio, B.V.; Silva, P.B.; Ramos, M.A.; Negri, K.M.; Bauab, T.M.; Chorilli, M. Nanotechnology-based drug delivery systems and herbal medicines: A review. Int. J. Nanomed. 2014, 9, 1–15.
  4. Hafez, D.A.; Elkhodairy, K.A.; Teleb, M.; Elzoghby, A.O. Nanomedicine-based approaches for improved delivery of phyto-therapeutics for cancer therapy. Expert Opin. Drug Deliv. 2020, 17, 279–285.
  5. Lim, C.L.; Raju, C.S.; Mahboob, T.; Kayesth, S.; Gupta, K.K.; Jain, G.K.; Dhobi, M.; Nawaz, M.; Wilairatana, P.; de Lourdes Pereira, M.; et al. Precision and advanced nano-phytopharmaceuticals for therapeutic applications. Nanomaterials 2022, 12, 238.
  6. Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; Rodriguez-Torres, M.D.P.; Acosta-Torres, L.S.; Diaz-Torres, L.A.; Grillo, R.; Swamy, M.K.; Sharma, S.; et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018, 16, 71.
  7. Watkins, R.; Wu, L.; Zhang, C.; Davis, R.M.; Xu, B. Natural product-based nanomedicine: Recent advances and issues. Int. J. Nanomed. 2015, 10, 6055–6074.
  8. Dowling, A.; Clift, R.; Grobert, N.; Hutton, D.; Oliver, R.; O’neill, O.; Pethica, J.; Pidgeon, N.; Porritt, J.; Ryan, J. Nanoscience and nanotechnologies: Opportunities and uncertainties, lond. R. Soc. R. Acad. Eng. Rep. 2004, 46, 618.
  9. Mishra, V.; Kesharwani, P.; Mohd Amin, M.C.I.; Iyer, A.K. (Eds.) Preface. In Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes; Elsevier: Amsterdam, The Netherlands, 2017; pp. xix–xx.
  10. Sandhiya, V.; Ubaidulla, U. A review on herbal drug loaded into pharmaceutical carrier techniques and its evaluation process. Future J. Pharm. Sci. 2020, 6, 1–16.
  11. Pelaz, B.; Alexiou, C.; Alvarez-Puebla, R.A.; Alves, F.; Andrews, A.M.; Ashraf, S.; Balogh, L.P.; Ballerini, L.; Bestetti, A.; Brendel, C.; et al. Diverse applications of nanomedicine. ACS Nano 2017, 11, 2313–2381.
  12. Mitchell, M.J.; Billingsley, M.M.; Haley, R.M.; Wechsler, M.E.; Peppas, N.A.; Langer, R. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 2021, 20, 101–124.
  13. Chen, G.; Roy, I.; Yang, C.; Prasad, P.N. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem. Rev. 2016, 116, 2826–2885.
  14. Sachan, A.K.; Gupta, A. A review on nanotized herbal drugs. Int. J. Pharma. Sci. Res. 2015, 6, 961.
  15. Morigi, V.; Tocchio, A.; Pellegrini, B.C.; Sakamoto, J.H.; Arnone, M.; Tasciotti, E. Nanotechnology in medicine: From inception to market domination. J. Drug Deliv. 2012, 2012, 389485.
  16. Hay, R.J.; Johns, N.E.; Williams, H.C.; Bolliger, I.W.; Dellavalle, R.P.; Margolis, D.J.; Marks, R.; Naldi, L.; Weinstock, M.A.; Wulf, S.K.; et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J. Invest. Dermatol. 2014, 134, 1527–1534.
  17. Barankin, B.; DeKoven, J. Psychosocial effect of common skin diseases. Can. Fam. Physician 2002, 48, 712–716.
  18. Hazarika, N.; Archana, M. The psychosocial impact of acne vulgaris. Ind. J. Dermatol. 2016, 61, 515–520.
  19. Mian, M.; Silfvast-Kaiser, A.; Paek, S.; Kivelevitch, D.; Menter, A. A review of the most common dermatologic conditions and their debilitating psychosocial impacts. Int. Arch. Int. Med. 2019, 3, 018.
  20. Essendoubi, M.; Gobinet, C.; Reynaud, R.; Angiboust, J.F.; Manfait, M.; Piot, O. Human skin penetration of hyaluronic acid of different molecular weights as probed by raman spectroscopy. Skin Res. Technol. 2016, 22, 55–62.
  21. Roberts, M.S.; Mohammed, Y.; Pastore, M.N.; Namjoshi, S.; Yousef, S.; Alinaghi, A.; Haridass, I.N.; Abd, E.; Leite-Silva, V.R.; Benson, H.; et al. Topical and cutaneous delivery using nanosystems. J. Control. Release 2017, 247, 86–105.
  22. Kocbek, P.; Teskač, K.; Kreft, M.E.; Kristl, J. Toxicological aspects of long-term treatment of keratinocytes with ZNO and TiO2 nanoparticles. Small 2010, 6, 1908–1917.
  23. Schaeffer, H.E.; Krohn, D.L. Liposomes in topical drug delivery. Invest. Ophthalmol. Vis. Sci. 1982, 22, 220–227.
  24. Haider, M.; Abdin, S.M.; Kamal, L.; Orive, G. Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics 2020, 12, 288.
  25. Xu, Y.; Guo, Y.; Yang, Y.; Meng, Y.; Xia, X.; Liu, Y. Stabilization of deformable nanovesicles based on insulin-phospholipid complex by freeze-drying. Pharmaceutics 2019, 11, 539.
  26. Chaiyana, W.; Anuchapreeda, S.; Punyoyai, C.; Neimkhum, W.; Lee, K.-H.; Lin, W.-C.; Lue, S.-C.; Viernstein, H.; Mueller, M. Ocimum sanctum linn. as a natural source of skin anti-ageing compounds. Ind. Crops Prod. 2019, 127, 217–224.
  27. Chaiyana, W.; Anuchapreeda, S.; Somwongin, S.; Marsup, P.; Lee, K.H.; Lin, W.C.; Lue, S.C. Dermal delivery enhancement of natural anti-ageing compounds from Ocimum sanctum linn. extract by nanostructured lipid carriers. Pharmaceutics 2020, 12, 309.
  28. Caddeo, C.; Díez-Sales, O.; Pons, R.; Fernàndez-Busquets, X.; Fadda, A.M.; Manconi, M. Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation. Pharm. Res. 2014, 31, 959–968.
  29. Kaur, L.; Jain, S.K.; Manhas, R.K.; Sharma, D. Nanoethosomal formulation for skin targeting of amphotericin B: An in vitro and in vivo assessment. J. Liposome Res. 2015, 25, 294–307.
  30. Ramezanli, T.; Kilfoyle, B.E.; Zhang, Z.; Michniak-Kohn, B.B. Polymeric nanospheres for topical delivery of vitamin D3. Int. J. Pharm. 2017, 516, 196–203.
  31. Petit, R.G.; Cano, A.; Ortiz, A.; Espina, M.; Prat, J.; Muñoz, M.; Severino, P.; Souto, E.B.; García, M.L.; Pujol, M.; et al. Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics. Int. J. Mol. Sci. 2021, 22, 4983.
  32. Chen, Y.; Wu, Q.; Zhang, Z.; Yuan, L.; Liu, X.; Zhou, L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012, 17, 5972–5987.
  33. Waghule, T.; Gorantla, S.; Rapalli, V.K.; Shah, P.; Dubey, S.K.; Saha, R.N.; Singhvi, G. Emerging trends in topical delivery of curcumin through lipid nanocarriers: Effectiveness in skin disorders. AAPS PharmSciTech 2020, 21, 284.
  34. Paul, A.K.; Jahan, R.; Paul, A.; Mahboob, T.; Bondhon, T.A.; Jannat, K.; Hasan, A.; Nissapatorn, V.; Wilairatana, P.; de Lourdes Pereira, M.; et al. The role of medicinal and aromatic plants against obesity and arthritis: A review. Nutrients 2022, 14, 985.
  35. Mahmood, A.; Rapalli, V.K.; Waghule, T.; Gorantla, S.; Dubey, S.K.; Saha, R.N.; Singhvi, G. Uv spectrophotometric method for simultaneous estimation of betamethasone valerate and tazarotene with absorption factor method: Application for in-vitro and ex-vivo characterization of lipidic nanocarriers for topical delivery. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2020, 235, 118310.
  36. Battaglia, L.; Gallarate, M. Lipid nanoparticle: State of the art, new preparation methods and challenges in drug delivery. Expert Opin. Drug Deliv. 2012, 9, 497–508.
  37. Moreno, L.; Puerta, E.; Suárez-Santiago, J.E.; Santos-Magalhães, N.S.; Ramirez, M.J.; Irache, J.M. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease. Int. J. Pharm. 2017, 517, 50–57.
  38. Shankar, G.M.; Antony, J.; Anto, R.J. Chapter two-quercetin and tryptanthrin: Two broad spectrum anticancer agents for future chemotherapeutic interventions. In The Enzymes; Bathaie, S.Z., Tamanoi, F., Eds.; Academic Press: Cambridge, MA, USA, 2015; Volume 37, pp. 43–72.
  39. Palle, S.; Neerati, P. Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats. Bull. Fac. Pharm. Cairo Univ. 2017, 55, 101–106.
  40. de Andrade Teles, R.B.; Diniz, T.C.; Costa Pinto, T.C.; de Oliveira Júnior, R.G.; Gama, E.S.M.; de Lavor, É.M.; Fernandes, A.W.C.; de Oliveira, A.P.; de Almeida Ribeiro, F.P.R.; da Silva, A.A.M.; et al. Flavonoids as therapeutic agents in Alzheimer’s and Parkinson’s diseases: A systematic review of preclinical evidences. Oxidative Med. Cell. Longev. 2018, 2018, 7043213.
  41. Kim, M.J.; Rehman, S.U.; Amin, F.U.; Kim, M.O. Enhanced neuroprotection of anthocyanin-loaded peg-gold nanoparticles against aβ (1-42)-induced neuroinflammation and neurodegeneration via the NF-(k)b/JNK/GSK3β signaling pathway. Nanomedicine 2017, 13, 2533–2544.
  42. Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr. Res. 2017, 61, 1361779.
  43. Cheng, K.K.; Yeung, C.F.; Ho, S.W.; Chow, S.F.; Chow, A.H.; Baum, L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer’s disease tg2576 mice. AAPS J. 2013, 15, 324–336.
  44. Zubedat, S.; Freed, Y.; Eshed, Y.; Cymerblit-Sabba, A.; Ritter, A.; Nachmani, M.; Harush, R.; Aga-Mizrachi, S.; Avital, A. Plant-derived nanoparticle treatment with cocc 30c ameliorates attention and motor abilities in sleep-deprived rats. Neuroscience 2013, 253, 1–8.
  45. Zhang, C.; Chen, J.; Feng, C.; Shao, X.; Liu, Q.; Zhang, Q.; Pang, Z.; Jiang, X. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer’s disease. Int. J. Pharm. 2014, 461, 192–202.
  46. Manca, M.L.; Manconi, M.; Meloni, M.C.; Marongiu, F.; Allaw, M.; Usach, I.; Peris, J.E.; Escribano-Ferrer, E.; Tuberoso, C.I.G.; Gutierrez, G. Nanotechnology for natural medicine: Formulation of neem oil loaded phospholipid vesicles modified with argan oil as a strategy to protect the skin from oxidative stress and promote wound healing. Antioxidants 2021, 10, 670.
  47. Maghimaa, M.; Alharbi, S.A. Green synthesis of silver nanoparticles from Curcuma longa l. and coating on the cotton fabrics for antimicrobial applications and wound healing activity. J. Photochem. Photobiol. B Biol. 2020, 204, 111806.
  48. Zamarioli, C.M.; Martins, R.M.; Carvalho, E.C.; Freitas, L.A. Nanoparticles containing curcuminoids (curcuma longa): Development of topical delivery formulation. Rev. Bras. Farmacogn. 2015, 25, 53–60.
  49. Masuku, N.P.; Unuofin, J.O.; Lebelo, S.L. Advances in nanoparticle delivery system for erectile dysfunction: An updated review. Sex. Med. 2021, 9, 100420.
  50. Draganski, A.; Tar, M.T.; Villegas, G.; Friedman, J.M.; Davies, K.P. Topically applied curcumin-loaded nanoparticles treat erectile dysfunction in a rat model of type-2 diabetes. J. Sex. Med. 2018, 15, 645–653.
  51. Linjawi, S.A. Evaluation of the protective effect of Panax ginseng nanoparticles against nicotine-induced reproductive disorders in male rats. Int. J. Pharma. Sci. Rev. Res. 2015, 32, 38–45.
  52. Das, P.; Kumar, K.; Nambiraj, A.; Awasthi, R.; Dua, K.; Malipeddi, H. Antibacterial and in vitro growth inhibition study of struvite urinary stones using Oxalis corniculata linn. leaf extract and its biofabricated silver nanoparticles. Recent Pat. Drug Deliv. Formul. 2018, 12, 170–178.
  53. Mishra, M.P.; Padhy, R.N. Antibacterial activity of green silver nanoparticles synthesized from Anogeissus acuminata against multidrug resistant urinary tract infecting bacteria in vitro and host-toxicity testing. J. App. Biomed. 2018, 16, 120–125.
  54. Santhoshkumar, J.; Kumar, S.V.; Rajeshkumar, S. Synthesis of zinc oxide nanoparticles using plant leaf extract against urinary tract infection pathogen. Resour. Effic. Technol. 2017, 3, 459–465.
  55. Paralikar, P.; Ingle, A.P.; Tiwari, V.; Golinska, P.; Dahm, H.; Rai, M. Evaluation of antibacterial efficacy of sulfur nanoparticles alone and in combination with antibiotics against multidrug-resistant uropathogenic bacteria. J. Environ. Sci. Health Part A Toxic Hazard Subst. Environ. Eng. 2019, 54, 381–390.
  56. Yogapiya, R.; Balakrishnaraja, R.; Gowthamraj, G. Comparative analysis and synthesis of silver nano-particles from selected parts of Mimosa pudica to treat urinary tract infection. Res. Sq. 2021; preprint.
  57. Ranjan, M.P.; Das, M.P.; Kumar, M.S.; Anbarasi, P.; Sindhu, S.; Sagadevan, E.; Arumugam, P. Green synthesis and characteriza-tion of silver nanoparticles from Nigella sativa and its application against UTI causing bacteria. J. Acad. Ind. Res. 2013, 2, 45–49.
  58. Alshahrani, M.Y.; Rafi, Z.; Alabdallah, N.M.; Shoaib, A.; Ahmad, I.; Asiri, M.; Zaman, G.S.; Wahab, S.; Saeed, M.; Khan, S. A comparative antibacterial, antioxidant, and antineoplastic potential of Rauwolfia serpentina (l.) leaf extract with its biologically synthesized gold nanoparticles (r-aunps). Plants 2021, 10, 2278.
  59. Manson, J.E.; Chlebowski, R.T.; Stefanick, M.L.; Aragaki, A.K.; Rossouw, J.E.; Prentice, R.L.; Anderson, G.; Howard, B.V.; Thomson, C.A.; LaCroix, A.Z.; et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women’s health initiative randomized trials. JAMA 2013, 310, 1353–1368.
  60. Chen, M.N.; Lin, C.C.; Liu, C.F. Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review. Climacteric 2015, 18, 260–269.
  61. Mathur, M.; Vyas, G. Role of nanoparticles for production of smart herbal drug-An overview. Indian J. Nat. Prod. Resour. 2013, 4, 329–338.
  62. Tang, J.; Xu, N.; Ji, H.; Liu, H.; Wang, Z.; Wu, L. Eudragit nanoparticles containing genistein: Formulation, development, and bioavailability assessment. Int. J. Nanomed. 2011, 6, 2429.
  63. Bilal, I.; Chowdhury, A.; Davidson, J.; Whitehead, S. Phytoestrogens and prevention of breast cancer: The contentious debate. World J. Clin. Oncol. 2014, 5, 705–712.
  64. Huang, L.; Wang, Z.; Liu, G.; Wu, Y.; Yang, C.; Mei, L.; Zhang, H.; Zeng, X. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int. J. Nanomed. 2015, 10, 2461–2473.
  65. Johnson, A.; Roberts, R.L.; Elkins, G. Complementary and alternative medicine for menopause. J. Evid. Based Integr. Med. 2019, 24, 2515690X19829380.
  66. Ruhlen, R.L.; Sun, G.Y.; Sauter, E.R. Black cohosh: Insights into its mechanism(s) of action. Integr. Med. Insights 2008, 3, 21–32.
  67. Masserini, M. Nanoparticles for brain drug delivery. ISRN Biochem. 2013, 2013, 238428.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
Video Production Service
Feedback